Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Court sentences Purdue Pharma to pay $5.5B, clearing settlement path
April 28 (UPI) -- A federal judge on Tuesday sentenced Purdue Pharma to pay more than $5 billion in criminal penalties, clearing the way for the OxyContin maker to complete its bankruptcy settlement agreement and resolve thousands of opioid-related…
OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
A federal judge sentenced OxyContin manufacturer Purdue Pharma on Tuesday, ordering the company to pay over $5 billion in criminal penalties. The pharmaceutical company will soon dissolve, as the sentencing was the last step before Purdue Pharma…
Purdue Pharma to Pay $225 Million to Justice Department
A federal judge has sentenced OxyContin maker Purdue Pharma to pay the government $225 million, ending the government's yearslong criminal case and allowing the pharmaceutical company accused of fueling the opioid epidemic to wrap up a settlement…
Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement
Drew Angerer | Getty Images News | Getty Images OxyContin maker Purdue Pharma was sentenced on Tuesday to $5.5 billion in fines and penalties stemming from its 2020 guilty plea to charges of deceiving government regulators and paying kickbacks to…
Judge OKs OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves
NEWARK, N.J. — OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week's end, as a massive legal settlement resolving thousands of lawsuits takes effect. A federal judge on…
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
MUMBAI, India, April 28, 2026 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and…
OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
Seth Wenig People rally outside a courthouse while a hearing for Purdue Pharma takes place inside in Newark, N.J., Tuesday, April 21, 2026. (AP Photo/Seth Wenig) Updated: 8:24 PM EDT Apr 28, 2026 OxyContin maker Purdue Pharma set to dissolve after…
Judge approves OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves
OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week's end, as a massive legal settlement resolving thousands of lawsuits takes effect. A federal judge on Tuesday delivered a criminal…
Nuvectis Pharma (NVCT) Projected to Post Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) is anticipated to post its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect Nuvectis Pharma to post earnings of ($0.30) per share for the quarter. Individuals may review…
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Down 8% - What's Next?
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report)'s stock price traded down 8% during mid-day trading on Tuesday. The stock traded as low as $28.03 and last traded at $28.0210. 743,035 shares were traded during trading, a decline of…
OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
Jessica Hill FILE - In this Aug. 17, 2018, file photo, family and friends who have lost loved ones to OxyContin and opioid overdoses leave pill bottles in protest outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in…
BridgeBio Pharma (NASDAQ:BBIO) Earns 'Outperform' Rating from Mizuho
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report)'s stock had its 'outperform' rating reaffirmed by Mizuho in a note issued to investors on Tuesday, Benzinga reports. They currently have a $106.00 price objective on the stock. Mizuho's target price…
Pharmalittle: We're reading about warnings over Trump's MFN plan, Purdue Pharma sentencing, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where clear blue skies and pleasant breezes are greeting us. Who could ask for anything more? Actually, we could —…
Ascendis Pharma A/S (NASDAQ:ASND) Sees Unusually-High Trading Volume - Here's What Happened
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) saw unusually-strong trading volume on Tuesday. Approximately 1,372,202 shares changed hands during mid-day trading, an increase of 99% from the previous session's volume of 688,497…
Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack (NYSE:DOCS)
Doximity has seen a two-thirds stock price decline, which I attribute mainly to market overreaction and short-term uncertainty, not deteriorating fundamentals. DOCS maintains a robust business model with 90% gross margins, ~30% net margins, strong…
Receive a Daily briefing on Pharma Industry News
Get Started